Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maibang Biotech is a leading Chinese life sciences company focused on the development and large-scale production of high-end chemically defined cell culture media. The company provides critical upstream raw materials and technical services for the biopharmaceutical industry, supporting the production of monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Maibang's core offerings include specialized media for CHO, HEK293, and insect cell lines, as well as customized media formulation and process optimization services. Headquartered in Shanghai, the company operates state-of-the-art GMP manufacturing facilities designed to meet international quality standards. Maibang is positioned as a key player in the localization of the bioprocessing supply chain, serving a broad range of domestic and international biotech clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Maibang Biotechnology.